The U.S. Department of Health and Human Services (HHS), Office for Civil Rights (OCR), issued a Request for Information (RFI) Dec. 12 seeking input from the public on how the Health Insurance Portability and Accountability Act (HIPAA) Rules, especially the HIPAA Privacy Rule, could be modified to further

Alton Shader, formerly president of Hill-Rom’s global Front Line Care business, has been named president and CEO of Vein Clinics of America (VCA), a Frazier Healthcare Partners  portfolio company, replacing Hans Thunem. A VCA release indicated that Thunem, who was CEO for four years, made the decision earlier in 2018

 ‘A Wonderful Resource’   By Joseph D. Raffetto, MD “A Guide to Treating Face Veins” is a wonderful resource and compilation of work by Dr. Ronald Bush and Mrs. Peggy Bush. Facial veins are uncommonly treated in most clinical practices but is a common problem among patients who seek medical

    “My veins are covered by insurance, right? But, the XYZ Insurance Co. representative said my varicose veins are a covered benefit on my insurance plan.”    By James White, MD How many times have these words been uttered by potential patients upon arrival to our vein clinics? Yet,

  Phlebologist compares practicing specialized medicine abroad     By Emma Stout, MD I grew up in Italy, idolizing my grandfather, who was a surgeon. With his influence, I became passionate about the medical field, specifically practicing specialized medicine and providing the best possible care for all patients. I am

    The CEO of Vein911 Vein Treatment Centers, 21-year cancer survivor and healthcare industry veteran Chris Pittman, MD, has launched Health Performance Specialists (HPS), a national Management Services Organization for independent physicians. HPS helps independent physicians compete, succeed and thrive in today’s medical practice environment. The organization is designed to disrupt current healthcare

By Vanessa Salvia The American College of Phlebology (ACP) has changed its name to the American Vein & Lymphatic Society (AVLS). The organization is still working on its new logo. The American College of Phlebology Foundation will be known as the Foundation for Venous and Lymphatic Disease, or FVLD. During

    Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG plc., a United Kingdom-based company that develops and commercializes products used in minimally-invasive procedures, targeting vascular diseases and cancer, as well as acute care pharmaceuticals. Under the terms of the transaction, holders

The U.S. Department of Health and Human Services’ second edition of the Physical Activity Guidelines for Americans was released at the American Heart Association’s Scientific Sessions meeting Nov. 11. The second edition provides evidence-based recommendations for youth ages 3 through 17 and adults to safely get the physical activity they

  BTG plc highlighted the presentation of the two-year results for the SENTRY Trial at the Vascular Interventional Advances (VIVA) conference in Las Vegas. The prospective, multicenter trial of the BTG Sentry, the world’s first bioconvertible IVC filter, found that in addition to providing protection against pulmonary embolism (PE) during the